Insights on the Lyophilized Injectable Global Market to 2031 - Featuring Baxter International, BD and Aristopharma Among Others

Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Lyophilized Injectable Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

This report on the global lyophilized injectable market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the global lyophilized injectable market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global lyophilized injectable market from 2021 to 2031.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global lyophilized injectable market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global lyophilized injectable market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global lyophilized injectable market. These serve as valuable tools for existing market players as well as entities interested in participating in the global lyophilized injectable market.

The report also delves into the competitive landscape of the global lyophilized injectable market. Key players operating in the global lyophilized injectable market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global lyophilized injectable market that have been profiled in this report.

Key Questions Answered in the Report

• What is the sales/revenue generated by lyophilized injectable providers across all regions during the forecast period?

• What are the opportunities in the global lyophilized injectable market?

• What are the major drivers, restraints, opportunities, and threats in the global market?

• Which region is set to expand at the fastest CAGR during the forecast period?

• Which application segment is expected to generate the highest revenue globally in 2030?

• What are the market positions of different companies operating in the global market?

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Lyophilized Injectable Market

4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Lyophilized Injectable Market Analysis and Forecast, 2017-2031

5. Market Outlook
5.1. COVID-19 Pandemics Impact on Industry
5.2. Key Industry Developments
5.3. Pipeline Analysis
5.4. Top 10 Lyophilized Drug Products
5.5. Regulatory Scenario

6. Global Lyophilized Injectable Market Analysis and Forecast, by Type of Packaging
6.1. Introduction & Definition
6.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017-2031
6.2.1. Single-use Vials
6.2.2. Point-of-care Reconstitution
6.2.3. Specialty Packaging
6.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging

7. Global Lyophilized Injectable Market Analysis and Forecast, by Type of Delivery
7.1. Introduction & Definition
7.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017-2031
7.2.1. Prefilled Diluent Syringes
7.2.2. Proprietary Reconstitution Devices
7.2.3. Single-step Devices
7.2.4. Multi-step Devices
7.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery

8. Global Lyophilized Injectable Market Analysis and Forecast, by Indication
8.1. Introduction & Definition
8.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017-2031
8.2.1. Autoimmune Diseases
8.2.2. Metabolic Conditions
8.2.3. Infectious Diseases
8.2.4. Others
8.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Indication

9. Global Lyophilized Injectable Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017-2031
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers
9.2.3. Specialty Clinics
9.2.4. Others
9.3. Global Lyophilized Injectable Market Attractiveness Analysis, by End-user

10. Global Lyophilized Injectable Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Region

11. North America Lyophilized Injectable Market Analysis and Forecast

12. Europe Lyophilized Injectable Market Analysis and Forecast

13. Asia Pacific Lyophilized Injectable Market Analysis and Forecast

14. Latin America Lyophilized Injectable Market Analysis and Forecast

15. Middle East & Africa Lyophilized Injectable Market Analysis and Forecast

16. Competition Landscape
16.1. Market Position Analysis, by Company, 2019
16.2. Company Profiles
16.2.1. B. Braun Melsungen AG
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Growth Strategies
16.2.1.3. SWOT Analysis
16.2.2. Baxter International, Inc.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Growth Strategies
16.2.2.3. SWOT Analysis
16.2.3. BD
16.2.3.1. Company Overview (HQ, Business Segments)
16.2.3.2. Growth Strategies
16.2.3.3. SWOT Analysis
16.2.4. SCHOTT AG
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Growth Strategies
16.2.4.3. SWOT Analysis
16.2.5. Aristopharma Ltd.
16.2.5.1. Company Overview (HQ, Business Segments)
16.2.5.2. Growth Strategies
16.2.5.3. SWOT Analysis
16.2.6. Vetter Pharma
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Growth Strategies
16.2.6.3. SWOT Analysis
16.2.7. Jubilant HollisterStier LLC
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Growth Strategies
16.2.7.3. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/104jcx

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900